Expanding CAR-T cell efficacy beyond liquid blood cancers into solid tumor indications represents the primary frontier in cellular oncology research. Detailed analysis within the CAR T Cell Therapy Market report highlights how novel "armored" CAR-Ts, dual-antigen targeting constructs, and logic-gated (AND/OR) receptors penetrate dense solid tumor microenvironments. Armored CAR-Ts secrete...